News Snapshot:
China has challenges, though, as the epidemic has petered out in the country, hampering efforts to conduct large trials. It has since shifted its focus overseas, but only a handful of countries have shown willingness to collaborate – UAE, Canada, Brazil, Indonesia and Mexico. Neither major European countries nor the United States have shown interest in China’s COVID-19 vaccine s as they focus on their own projects. China must also address concerns over its vaccine quality and safety issues following several over substandard vaccine s in recent years. “The Chinese national regulatory authority has been improving its oversight,†said Jerome...
